UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Visit-to-Visit Low-Density Lipoprotein Cholesterol Variability and Risk of Cardiovascular Outcomes

Journal of the American College of Cardiology, 2015-04, Vol.65 (15), p.1539-1548

2015

Volltextzugriff (PDF)

Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial

Journal of the American College of Cardiology, 2015-04, Vol.65 (15), p.1539-1548

2015

Volltextzugriff (PDF)

Effects of Serelaxin on the Outcome of Patients with or without Substantial Peripheral edema: A Subgroup Analysis from the RELAX-AHF Trial

The American heart journal, 2017-08, Vol.190, p.113-122

2017

Volltextzugriff (PDF)

Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease

Arthritis & rheumatology (Hoboken, N.J.), 2012-09, Vol.64 (9), p.2836-2846

2012

Volltextzugriff (PDF)

Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naive or relapsed / refractory mantle cell lymphoma: phase Ib trial

Haematologica (Roma), 2024-09

2024

Volltextzugriff (PDF)

Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia

Therapeutic advances in hematology, 2023-01, Vol.14, p.20406207231173489-20406207231173489

2023

Volltextzugriff (PDF)

J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial

European heart journal, 2010-12, Vol.31 (23), p.2897-2908

2010

Volltextzugriff (PDF)

Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin: Results From 3 Large Randomized Clinical Trials

Journal of the American College of Cardiology, 2011-04, Vol.57 (14), p.1535-1545

2011

Volltextzugriff (PDF)

Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels

International journal of cardiology, 2013-10, Vol.168 (4), p.3846-3852

2013

Volltextzugriff (PDF)

LADA and CARDS: A Prospective Study of Clinical Outcome in Established Adult-Onset Autoimmune Diabetes

Diabetes care, 2014-06, Vol.37 (6), p.1643-1649

2014

Volltextzugriff (PDF)

Relationship Between Cardiovascular Risk Factors and Atherosclerotic Disease Burden Measured by Intravascular Ultrasound

Journal of the American College of Cardiology, 2006-05, Vol.47 (10), p.1967-1975

2006

Volltextzugriff (PDF)

Ventricular Dysfunction and the Risk of Stroke after Myocardial Infarction

The New England journal of medicine, 1997-01, Vol.336 (4), p.251-257, Article 251

1997

Volltextzugriff (PDF)

Impact of Smoking on Cardiovascular Events in Patients With Coronary Disease Receiving Contemporary Medical Therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] Trials)

The American journal of cardiology, 2011-01, Vol.107 (2), p.145-150

2011

Volltextzugriff (PDF)

A Meta-analysis of Factors Impacting Detection of Antidepressant Efficacy in Clinical Trials: The Importance of Academic Sites

Neuropsychopharmacology (New York, N.Y.), 2012-12, Vol.37 (13), p.2830-2836

2012

Volltextzugriff (PDF)

Diagnostic Marker Cooperative Study for the diagnosis of myocardial infarction

Circulation (New York, N.Y.), 1999-04, Vol.99 (13), p.1671-1677

1999

Volltextzugriff (PDF)

P1094: SAFETY AND EFFICACY OF ACALABRUTINIB, BENDAMUSTINE, AND RITUXIMAB IN PATIENTS WITH TREATMENT‐NAIVE OR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: PHASE IB TRIAL

HemaSphere, 2023-08, Vol.7 (S3), p.e64204bc-n/a

2023

Volltextzugriff (PDF)

Effects of Increasing Doses of Atorvastatin on the Atherogenic Lipid Subclasses Commonly Associated With Hypertriglyceridemia

The American journal of cardiology, 2007-08, Vol.100 (3), p.445-449

2007

Volltextzugriff (PDF)

Relation of Improvement in Estimated Glomerular Filtration Rate With Atorvastatin to Reductions in Hospitalizations for Heart Failure (from the Treating to New Targets [TNT] Study)

The American journal of cardiology, 2012-06, Vol.109 (12), p.1761-1766

2012

Volltextzugriff (PDF)

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

The New England journal of medicine, 1996-10, Vol.335 (14), p.1001-1009

1996

Volltextzugriff (PDF)

Kinematic flowrate characteristics of external spur gear pumps using an exact closed solution

Mechanism and machine theory, 2009-06, Vol.44 (6), p.1121-1131

2009

Volltextzugriff (PDF)

Rationale and Design of the Avoiding Cardiovascular events through COMbination therapy in Patients LIving with Systolic Hypertension (ACCOMPLISH) trial: The first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension

American journal of hypertension, 2004-09, Vol.17 (9), p.793-801

2004

Volltextzugriff (PDF)

Effects of Obesity on Lipid-Lowering, Anti-Inflammatory, and Antiatherosclerotic Benefits of Atorvastatin or Pravastatin in Patients With Coronary Artery Disease (from the REVERSAL Study)

The American journal of cardiology, 2006-06, Vol.97 (11), p.1553-1557

2006

Volltextzugriff (PDF)

Childhood and adolescent physical activity patterns and adult physical activity

Medicine and science in sports and exercise, 1999, Vol.31 (1), p.118-123

1999

Volltextzugriff (PDF)

Prediction of cardiovascular events in patients with ankylosing spondylitis and psoriatic arthritis: role of lipoproteins in a high-risk population

Journal of rheumatology, 2012-07, Vol.39 (7), p.1433-1440

2012

Volltextzugriff (PDF)

Effect of infarct artery patency on prognosis after acute myocardial infarction

Circulation (New York, N.Y.), 1995-09, Vol.92 (5), p.1101-1109

1995

Volltextzugriff (PDF)

1 – 25 von 181

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(149)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Visit-to-Visit Low-Density Lipoprotein Cholesterol Variability and Risk of Cardiovascular Outcomes

Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial

Effects of Serelaxin on the Outcome of Patients with or without Substantial Peripheral edema: A Subgroup Analysis from the RELAX-AHF Trial

Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease

Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naive or relapsed / refractory mantle cell lymphoma: phase Ib trial

Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia

J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial

Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin: Results From 3 Large Randomized Clinical Trials

Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels

LADA and CARDS: A Prospective Study of Clinical Outcome in Established Adult-Onset Autoimmune Diabetes

Relationship Between Cardiovascular Risk Factors and Atherosclerotic Disease Burden Measured by Intravascular Ultrasound

Ventricular Dysfunction and the Risk of Stroke after Myocardial Infarction

Impact of Smoking on Cardiovascular Events in Patients With Coronary Disease Receiving Contemporary Medical Therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] Trials)

A Meta-analysis of Factors Impacting Detection of Antidepressant Efficacy in Clinical Trials: The Importance of Academic Sites

Diagnostic Marker Cooperative Study for the diagnosis of myocardial infarction

P1094: SAFETY AND EFFICACY OF ACALABRUTINIB, BENDAMUSTINE, AND RITUXIMAB IN PATIENTS WITH TREATMENT‐NAIVE OR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: PHASE IB TRIAL

Effects of Increasing Doses of Atorvastatin on the Atherogenic Lipid Subclasses Commonly Associated With Hypertriglyceridemia

Relation of Improvement in Estimated Glomerular Filtration Rate With Atorvastatin to Reductions in Hospitalizations for Heart Failure (from the Treating to New Targets [TNT] Study)

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

Kinematic flowrate characteristics of external spur gear pumps using an exact closed solution

Rationale and Design of the Avoiding Cardiovascular events through COMbination therapy in Patients LIving with Systolic Hypertension (ACCOMPLISH) trial: The first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension

Effects of Obesity on Lipid-Lowering, Anti-Inflammatory, and Antiatherosclerotic Benefits of Atorvastatin or Pravastatin in Patients With Coronary Artery Disease (from the REVERSAL Study)

Childhood and adolescent physical activity patterns and adult physical activity

Prediction of cardiovascular events in patients with ankylosing spondylitis and psoriatic arthritis: role of lipoproteins in a high-risk population

Effect of infarct artery patency on prognosis after acute myocardial infarction

Suchergebnisse filtern